April 2, 2020

CEO-interview by MedTech Magazine

Inossia® prepares for market launch. CEO Malin Nilsson talked with MedTech Maganize.

Read on

May 19, 2020

Investor's choice

During the Connect Day on the 19th of May 2020, Inossia® was awarded the Investors' choice award!

Connect Uppsala chose Inossia® out of all companies that pitched in-front of their investor network during the entire 2019.

The motivation:

Connect has the honor of awarding Malin & Cecilia from Inossia the "Investors’ Choice" award. Inossia pitched during Q3 and impressed greatly on Uppsala Investor Network and managed to raise capital from a number of members. With their drive, complementary skills and fantastic product, they have won the hearts of the investors.

Read on

June 17, 2020

New bone cement softener for better treatment of bone fractures

Article published in OsteoporosNytt, a Journal from the Osteoporosis Association of Sweden.

Read on

July 3, 2020

Inossia® signs Global Distribution Agreement with G21 in Italy

This agreement will expand the market for G21 and at the same time we will have the possibility to create awareness of our coming product, the soft cement. We are very happy about this agreement and look forward to the launch of our soft cement.

July 23, 2020

Ethical approval granted in Spain

The Spanish ethics committee has granted us ethical approval to proceed with the clinical studies of our Soft Cement, which are planned to start in the fall 2020. In Spain, clinical studies will be carried out at our two collaborating clinics: Parc Sanitari Sant Joan de Déu in Barcelona, and Hospital Universitario Puerta de Hierro in Madrid.

September 28, 2020

Inossia® presented during Republic of Korea state visit

Our CEO, Malin Nilsson, presented Inossia® to the Speaker of the National Assembly of Korea, H.E Mr Park Byeong-seug and His delegation at Uppsala castle. The visit was hosted by the Governor of the Uppsala province, Mr Göran Enander.

Read on (in Swedish)


Check out our news and press releases


Phone: +46 702 688674


Copyright © All Rights Reserved